Rani Therapeutics Holdings, Inc.

NASDAQ:RANI

Biotechnology

Healthcare
$0.80 -5.22%

-$0.04 today

Market cap
$52.19M
Beta
0.76
P/E (TTM)
-4.6
EPS (TTM)
-$0.16
52W Low $0.39High $3.87

Volume 0.23M

Average 1.15M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$18.71M

FY 2025 · Annual

Investing Cash Flow

-$7.03M

FY 2025 · Annual

Financing Cash Flow

$40.30M

FY 2025 · Annual

+196.7% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(8.33M)(63.34M)(33.97M)(56.58M)(29.67M)
Depreciation & Amortization497K548K822K1.03M900K
Deferred Income Tax00000
Stock-Based Compensation22.6M15.78M19.01M16.03M11.8M
Change in Working Capital(3.43M)509K(2.14M)(544K)6.96M
Accounts Receivables000(428K)(1.61M)
Inventory00000
Accounts Payables543K163K(595K)711K(1.05M)
Other Working Capital(3.97M)346K(1.55M)(827K)9.62M
Other Non-Cash Items(43.58M)(10K)(34.96M)4.57M(8.7M)
Operating Cash Flow(32.25M)(46.52M)(51.24M)(35.5M)(18.71M)
Capital Expenditures(506K)(1.62M)(1.23M)(268K)(88K)
Acquisitions (Net)0(851K)000
Purchases of Investments0(73.82M)(73.26M)(58.72M)(33.97M)
Sales of Investments03M104.35M77.55M26.75M
Other Investing Activities0851K01.25M278K
Investing Cash Flow(506K)(72.44M)29.86M19.81M(7.03M)
Debt Repayment(2.85M)29.57M0(5M)(20.72M)
Common Stock Issued73.65M317K395K18.63M61.08M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities26K(886K)(162K)(47K)(59K)
Financing Cash Flow77.15M29.01M233K13.59M40.3M
Effect of Forex Changes00000
Net Change in Cash44.4M(89.95M)(21.14M)(2.1M)14.56M
Free Cash Flow(32.75M)(48.13M)(52.47M)(35.76M)(18.8M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$29.7M
+ D&A$900.0K
+ Stock-Based Comp$11.8M
+ Deferred Tax$0
+ Working Capital$7.0M
- Other Non-Cash-$8.7M
= Operating Cash Flow-$18.7M
- Capex-$88.0K
= Free Cash Flow-$18.8M

Analysis

FY2025 free cash flow is -$18.8M. FCF conversion is 63.4% of net income. Operating cash flow was -$18.7M, with capex of -$88.0K. The largest bridge item is Stock-Based Comp at $11.8M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipSep 29, 2026
4Statement of changes in beneficial ownershipSep 29, 2026
SC 13G/ASC 13G/A filingAug 14, 2026
10-QQuarterly reportAug 13, 2026
8-KCurrent reportAug 13, 2026

Does RANI generate free cash flow?

Rani Therapeutics Holdings, Inc. (RANI) generated -$18.80M of free cash flow in fiscal 2025.

How much operating cash flow does RANI produce?

Operating cash flow was -$18.71M, before capital expenditures of $88,000.00.